Cargando…

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine

The live-attenuated Japanese encephalitis chimeric virus vaccine JE-CV (IMOJEV®, Sanofi Pasteur) elicits a robust antibody response in children, which wanes over time. Clinical efficacy is based on a correlate of protection against JE infection defined as neutralizing antibody levels equal to or gre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouckenooghe, Alain, Bailleux, Fabrice, Feroldi, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363153/ https://www.ncbi.nlm.nih.gov/pubmed/30230947 http://dx.doi.org/10.1080/21645515.2018.1515455

Ejemplares similares

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization
por: Feroldi, Emmanuel, et al.
Publicado: (2017)

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine
por: Hills, Susan L., et al.
Publicado: (2021)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2019)

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
por: Jia, Na, et al.
Publicado: (2011)

Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(®)) in South Korea, 2015–2019
por: Kim, Hee Soo, et al.
Publicado: (2020)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
por: Mishra, Niraj, et al.
Publicado: (2020)

Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia
por: Islam, Nazmul, et al.
Publicado: (2022)

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model
por: Tesh, Robert B., et al.
Publicado: (2002)

Molecular and clinical relationship between live‐attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
por: He, Dan, et al.
Publicado: (2018)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

Safety of Japanese encephalitis vaccines
por: Hu, Ya-Li, et al.
Publicado: (2021)

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
por: Thomas, Rasmi, et al.
Publicado: (2022)

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
por: Madhi, Shabir A., et al.
Publicado: (2019)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Effectiveness of Live-Attenuated Genotype III Japanese Encephalitis Viral Vaccine against Circulating Genotype I Viruses in Swine
por: Fan, Yi-Chin, et al.
Publicado: (2022)

Generation of an Attenuated Chimeric Bat Influenza A Virus Live-Vaccine Prototype
por: Ran, Wei, et al.
Publicado: (2022)

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
por: Li, Xiao-Feng, et al.
Publicado: (2018)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Polytopic vaccination with a live-attenuated dengue vaccine enhances B-cell and T-cell activation, but not neutralizing antibodies
por: Hunsawong, Taweewun, et al.
Publicado: (2017)

Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children
por: Yegorov, Sergey, et al.
Publicado: (2022)

Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine
por: DeMaso, Christina R, et al.
Publicado: (2022)

A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Chin, Wei-Xin, et al.
Publicado: (2021)

The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine
por: Connor, Bradley, et al.
Publicado: (2017)

Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021)

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
por: Hills, Susan L., et al.
Publicado: (2019)

Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
por: Saga, Ryohei, et al.
Publicado: (2016)

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
por: Matsuoka, Osamu, et al.
Publicado: (2017)

Gianotti-Crosti syndrome following Japanese encephalitis vaccination.
por: Kang, Nam Gyu, et al.
Publicado: (2003)

Inactivated genotype 1 Japanese encephalitis vaccine for swine
por: Yang, Dong-Kun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_31mcfl2904agibuue785mlrb9e